Skip to content

Drug interactions

Repaglinide + Somapacitan

Severity: Moderate

Repaglinide and Somapacitan: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Growth hormone analogs can reduce insulin sensitivity, which may weaken the glucose-lowering effect of repaglinide. Growth hormone may also induce CYP3A4 activity and modestly lower repaglinide exposure.

What this interaction means in plain words

Repaglinide and Somapacitan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Repaglinide belongs to Endocrine; Somapacitan belongs to Endocrine.

Evidence level: Moderate

Why it happens

Growth hormone causes insulin resistance (pharmacodynamic antagonism) and may increase CYP450 activity.

What to do

Monitor blood glucose after starting somapacitan and increase the repaglinide dose if control worsens. Reassess if the growth hormone dose changes.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Repaglinide and Somapacitan, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Repaglinide with Somapacitan?

MediHelp rates the interaction as moderate. Repaglinide and Somapacitan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Growth hormone analogs can reduce insulin sensitivity, which may weaken the glucose-lowering effect of repaglinide. Growth hormone may also induce CYP3A4 activity and modestly lower repaglinide exposure.

How serious is the interaction between Repaglinide and Somapacitan?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose after starting somapacitan and increase the repaglinide dose if control worsens. Reassess if the growth hormone dose changes.

What other medicines interact with Repaglinide?

MediHelp also lists interactions of Repaglinide with, for example, Gemfibrozil, Clarithromycin, Clopidogrel. The full list is on the Repaglinide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in